X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (14) 14
male (13) 13
female (11) 11
adult (10) 10
hematology (10) 10
middle aged (10) 10
life sciences (9) 9
aged (8) 8
abridged index medicus (6) 6
cancer (6) 6
multiple myeloma - mortality (6) 6
survival analysis (6) 6
chemotherapy (5) 5
multiple myeloma (5) 5
multiple myeloma - drug therapy (5) 5
prospective studies (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
bortezomib (4) 4
disease-free survival (4) 4
melphalan - administration & dosage (4) 4
multiple myeloma - therapy (4) 4
therapy (4) 4
transplantation (4) 4
treatment outcome (4) 4
antineoplastic agents - therapeutic use (3) 3
disease (3) 3
france (3) 3
immunology (3) 3
immunophenotyping (3) 3
multiple myeloma - pathology (3) 3
oncology (3) 3
remission induction (3) 3
staging system (3) 3
survival rate (3) 3
transplantation, autologous (3) 3
adolescent (2) 2
analysis (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents, alkylating - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
autologous transplantation (2) 2
biclonal (2) 2
biphenotypic (2) 2
bone marrow (2) 2
caryotype (2) 2
cll (2) 2
cyclophosphamide (2) 2
dexamethasone (2) 2
dexamethasone - administration & dosage (2) 2
dexamethasone - adverse effects (2) 2
drug therapy (2) 2
follow-up studies (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cell transplantation (2) 2
high-dose therapy (2) 2
hiv infection (2) 2
infectious diseases (2) 2
lenalidomide (2) 2
lymphoma (2) 2
lymphomas (2) 2
melphalan - adverse effects (2) 2
neoplasm staging (2) 2
prednisone - administration & dosage (2) 2
prognosis (2) 2
randomized-trial (2) 2
retrospective studies (2) 2
risk factors (2) 2
salvage therapy (2) 2
stem cell transplantation (2) 2
stem-cell transplantation (2) 2
thalidomide - administration & dosage (2) 2
thalidomide - adverse effects (2) 2
140 mg/m (1) 1
[ sdv ] life sciences [q-bio] (1) 1
abnormalities (1) 1
acquired immunodeficiency syndrome - complications (1) 1
acute (1) 1
acute lymphocytic leukemia (1) 1
acute myeloblastic-leukemia (1) 1
adults (1) 1
adverse and side effects (1) 1
adverse effects (1) 1
adverse prognostic-factor (1) 1
age factors (1) 1
aged patients (1) 1
aids/hiv (1) 1
anemia - chemically induced (1) 1
anti-hiv agents (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - therapeutic use (1) 1
antigens, cd - analysis (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents, alkylating - toxicity (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols/therapeutic use (1) 1
antiretrovirals (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 11/2015, Volume 90, Issue 11, pp. 986 - 991
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9594, pp. 1209 - 1218
Journal Article
Prenatal Diagnosis, ISSN 0197-3851, 12/2017, Volume 37, Issue 12, pp. 1257 - 1260
What is already known about this subject? Non invasive prenatal testing for fetal trisomies 13, 18, and 21 occasionally identifies maternal cancer. What does... 
CANCER | GENETICS & HEREDITY | PREGNANCY | OBSTETRICS & GYNECOLOGY | Pregnant women | Multiple myeloma | Nickel base alloys | Trisomy | Platinum compounds | Intermetallic compounds | Invasiveness | Abnormalities | Fetuses | Nickel compounds | Patients | Cancer | Index Medicus | Research Letters | Research Letter
Journal Article
Journal Article
American Journal of Case Reports, ISSN 1941-5923, 06/2018, Volume 19, pp. 763 - 766
BACKGROUND Myeloid sarcoma is a rare extramedullary soft tissue neoplasm composed of myeloblastic cells, usually associated to hematologic tumor disorders and... 
Myeloid | Sarcoma | Testicular neoplasms | Acute | Leukemia | Index Medicus
Journal Article
by Pertesi, Maroulio and Vallée, Maxime and Wei, Xiaomu and Revuelta, Maria V and Galia, Perrine and Demangel, Delphine and Oliver, Javier and Foll, Matthieu and Chen, Siwei and Perrial, Emeline and Garderet, Laurent and Corre, Jill and Leleu, Xavier and Boyle, Eileen M and Decaux, Olivier and Rodon, Philippe and Kolb, Brigitte and Slama, Borhane and Mineur, Philippe and Voog, Eric and Le Bris, Catherine and Fontan, Jean and Maigre, Michel and Beaumont, Marie and Azais, Isabelle and Sobol, Hagay and Vignon, Marguerite and Royer, Bruno and Perrot, Aurore and Fuzibet, Jean-Gabriel and Dorvaux, Véronique and Anglaret, Bruno and Cony-Makhoul, Pascale and Berthou, Christian and Desquesnes, Florence and Pegourie, Brigitte and Leyvraz, Serge and Mosser, Laurent and Frenkiel, Nicole and Augeul-Meunier, Karine and Leduc, Isabelle and Leyronnas, Cécile and Voillat, Laurent and Casassus, Philippe and Mathiot, Claire and Cheron, Nathalie and Paubelle, Etienne and Moreau, Philippe and Bignon, Yves-Jean and Joly, Bertrand and Bourquard, Pascal and Caillot, Denis and Naman, Hervé and Rigaudeau, Sophie and Marit, Gérald and Macro, Margaret and Lambrecht, Isabelle and Cliquennois, Manuel and Vincent, Laure and Helias, Philippe and Avet-Loiseau, Hervé and Moreno, Victor and Reis, Rui Manuel and Varkonyi, Judit and Kruszewski, Marcin and Vangsted, Annette Juul and Jurczyszyn, Artur and Zaucha, Jan Maciej and Sainz, Juan and Krawczyk-Kulis, Malgorzata and Wątek, Marzena and Pelosini, Matteo and Iskierka-Jażdżewska, Elzbieta and Grząśko, Norbert and Martinez-Lopez, Joaquin and Jerez, Andrés and Campa, Daniele and Buda, Gabriele and Lesueur, Fabienne and Dudziński, Marek and García-Sanz, Ramón and Nagler, Arnon and Rymko, Marcin and Jamroziak, Krzysztof and Butrym, Aleksandra and Canzian, Federico and Obazee, Ofure and Nilsson, Björn and Klein, Robert J and Lipkin, Steven M and McKay, James D and Dumontet, Charles
Leukemia, ISSN 0887-6924, 04/2019, Volume 33, Issue 9, pp. 2324 - 2330
Journal Article
Blood, ISSN 0006-4971, 05/2016, Volume 127, Issue 21, pp. 2569 - 2574
Journal Article
Blood, ISSN 0006-4971, 04/2007, Volume 109, Issue 8, pp. 3489 - 3495
Journal Article
Blood, ISSN 0006-4971, 01/2010, Volume 115, Issue 1, pp. 32 - 37
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2019, pp. JCO.19.01073 - JCO1901073
PURPOSEThe PRIMA study (ClinicalTrials.gov identifier: NCT00140582) established that 2 years of rituximab maintenance after first-line immunochemotherapy... 
Index Medicus
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2019, Volume 25, Issue 14, pp. 4224 - 4230
Purpose: Carfilzomib is a novel generation proteasome inhibitor. The Carmysap trial demonstrated that twice-weekly KMP (carfilzomib, melphalan, prednisone)... 
THERAPY | BORTEZOMIB | EFFICACY | ONCOLOGY | SAFETY | ELDERLY-PATIENTS
Journal Article
Annales de Biologie Clinique, ISSN 0003-3898, 05/2011, Volume 69, Issue 3, pp. 325 - 330
Journal Article
Blood, ISSN 0006-4971, 02/2006, Volume 107, Issue 4, pp. 1292 - 1298
Journal Article